EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:69229 - caerulomycin J
| Formula | C13H13N3O2 |
| Net Charge | 0 |
| Average Mass | 243.266 |
| Monoisotopic Mass | 243.10078 |
| SMILES | CC(=O)NCc1cc(O)cc(-c2ccccn2)n1 |
| InChI | InChI=1S/C13H13N3O2/c1-9(17)15-8-10-6-11(18)7-13(16-10)12-4-2-3-5-14-12/h2-7H,8H2,1H3,(H,15,17)(H,16,18) |
| InChIKey | IXDVQWRMMLGZLB-UHFFFAOYSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Actinoalloteichus cyanogriseus (ncbitaxon:65497) | - | PubMed (21770434) | Ethyl acetate extract of fermentation broth Strain: WH1 2216-6 |
| Roles Classification |
|---|
| Biological Roles: | bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. marine metabolite Any metabolite produced during a metabolic reaction in marine macro- and microorganisms. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| caerulomycin J (CHEBI:69229) has parent hydride 2,2'-bipyridine (CHEBI:30351) |
| caerulomycin J (CHEBI:69229) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin J (CHEBI:69229) has role bacterial metabolite (CHEBI:76969) |
| caerulomycin J (CHEBI:69229) has role marine metabolite (CHEBI:76507) |
| caerulomycin J (CHEBI:69229) is a acetamides (CHEBI:22160) |
| caerulomycin J (CHEBI:69229) is a bipyridines (CHEBI:50511) |
| caerulomycin J (CHEBI:69229) is a monohydroxypyridine (CHEBI:38182) |
| caerulomycin J (CHEBI:69229) is a pyridine alkaloid (CHEBI:26416) |
| IUPAC Name |
|---|
| N-[(4-hydroxy-2,2'-bipyridin-6-yl)methyl]acetamide |
| Registry Numbers | Sources |
|---|---|
| Reaxys:21856156 | Reaxys |
| Citations |
|---|